[1] Liang L. The effect of psychosocial nursing on elderly patients with chronic obstructive pulmonary disease[J].J Clin Nurs Res,2023,7(6):65-70.
[2] Nishida S, Ono Y. Genomic analysis of extensively drug-resistant Acinetobacter baumannii harbouring a conjugative plasmid containing aminoglycoside resistance transposon TnaphA6[J]. J Infect Public Health, 2024, 17(2):293-298. DOI: 10.1016/j.jiph.2023.12.004.
[3] 王国玉,胡舒环,王浩宇,等.老年下呼吸道感染的病原学特征及经鼻高流量湿化氧疗辅助的疗效分析[J].中国现代医学杂志,2023,33(22):58-63. DOI:10.3969/j.issn.1005- 8982.2023.22.011.
[4] 严菁敏,陈莹,于洁,等.基于LASSO-logistic回归的TB/HIV患者抗结核治疗结局影响因素研究[J].现代预防医学,2023,50(22):4039-4045,4051. DOI:10.20043/j.cnki.MPM.202306338.
[5] 刘雪娇,罗巍,张波,等.基于Lasso-Logistic回归构建美沙酮维持治疗门诊患者继续使用毒品风险预测模型[J].中华疾病控制杂志,2021,25(12):1369-1373,1402. DOI:10.16462/j.cnki.zhjbkz.2021.12.002.
[6] 涂盈盈,陈绍鹤.ICU患者呼吸机相关肺炎耐药菌感染发生及其影响因素分析[J].中国卫生检验杂志,2019,29(17):2145-2147.
[7] Wu JF, Jia J, Chen P, et al. Sarcopenia and its clinical correlation in elderly chronic obstructive pulmonary disease: a prospective cohort study[J]. Eur Rev Med Pharmacol Sci, 2023, 27(20):9762-9772. DOI: 10.26355/eurrev_202310_34150.
[8] Wang W, Zhu DN, Shao SS, et al. Closed thoracic drainage in elderly patients with chronic obstructive pulmonary disease complicated with spontaneous pneumothorax: a retrospective study[J]. World J Clin Cases, 2023, 11(27):6415-6423. DOI: 10.12998/wjcc.v11.i27.6415.
[9] Jiang Y, Chen Z, Nuerdawulieti B, et al. Factors associated with the core dimensions of spiritual health among older adults with chronic obstructive pulmonary disease: a cross-sectional study[J]. J Adv Nurs, 2024, 80(2):692-706. DOI: 10.1111/jan.15825.
[10] Hossein AP, Fazel D, Nima SN, et al. Prevalence of Acinetobacter baumannii with multiple drug resistance isolated from patients with ventilator-associated pneumonia from 2010 to 2020 in the world: a systematic review and meta-analysis[J]. Rev Res Med Microbiol,2024,35(1):23-35. DOI: 10.1097/MRM.0000000000000339.
[11] 张静,谭焰,雷靖,等.老年慢性阻塞性肺疾病急性加重病人病原体分布特点的单中心回顾性研究[J].实用老年医学,2022,36(12):1255-1258. DOI:10.3969/j.issn.1003-9198. 2022.12.017.
[12] Namaki Kheljan M, Hassanzadeh M, Srdari Jabedar M, et al. Characterization of disinfectant susceptibility profiles among clinical isolates of Acinetobacter baumannii in Ardabil, Iran[J]. Acta Microbiol Immunol Hung, 2023, 70(4):311-317. DOI: 10.1556/030.2023.02087.
[13] 张阳,焦雨佼,巩翠珂,等.慢阻肺患者鲍曼不动杆菌感染肺泡巨噬细胞凋亡机制的研究[J].中国病原生物学杂志,2022,17(9):1082-1085. DOI:10.13350/j.cjpb.220920.
[14] Wang Z, Sun X, Wang B, et al. Lasso-Logistic regression model for the identification of serum biomarkers of neurotoxicity induced by strychnos alkaloids[J]. Toxicol Mech Methods, 2023, 33(1):65-72. DOI: 10.1080/15376516.2022.2086088.
[15] Zhang S, Tang B, Yu M, et al. Development and validation of a radiomics model based on lymph-node regression grading after neoadjuvant chemoradiotherapy in locally advanced rectal cancer[J]. Int J Radiat Oncol Biol Phys, 2023, 117(4):821-833. DOI: 10.1016/j.ijrobp.2023. 05.027.
[16] 王鹏,宋秋鸣.预测重症肺炎患者发生鲍曼不动杆菌多重耐药的风险列线图模型建立[J].中国抗生素杂志,2022,47(4):399-404. DOI:10.3969/j.issn.1001-8689.2022.04.013.
[17] 任建伟,温明修,张建业,等.心脏外科术后多重耐药细菌感染的病原学特征与耐药性分析[J].中华微生物学和免疫学杂志,2023,43(10):740-748. DOI:10.3760/cma.j.cn112309-20230425-00110.
[18] Mohamad TS, Rahman JK, Ahmed AA, et al. Down-regulation of abaI, abaR, Bap and OmpA genes in Acinetobacter baumannii by ethanol extract of Glycyrrhiza glabra after toxicity assessment[J]. Cell Mol Biol (Noisy-le-grand), 2023, 69(12):194-200. DOI: 10.14715/cmb/2023.69.12.31.
[19] 黄匀,龚晨晨,付建宇,等.重症监护病房血流感染预后危险因素分析[J].中华危重病急救医学,2020,32(12):1440-1444. DOI:10.3760/cma.j.cn121430-20201016- 00675.
[20] 仇桑桑,许琴芬,陈静瑜,等.基于限制性立方样条模型分析肺移植受者多重耐药菌感染的危险因素[J].器官移植,2023,14(4):578-584. DOI:10.3969/j.issn.1674-7445. 2023.04.015.
[21] 蒋玮,谭波涛,文思阳,等.神经康复病房肺部多重耐药菌感染的病原学特点及影响因素分析[J].重庆医学,2023,52(4):497-501. DOI:10.3969/j.issn.1671-8348.2023.04.004.
[22] Kadaikunnan S, Alharbi N. Colistin-induced structural and biochemical changes in carbapenem-resistant Acinetobacter baumannii isolated from the hospital environment[J]. J Infect Public Health, 2023, 16 Suppl 1:26-32. DOI: 10.1016/j.jiph.2023.11.011.
[23] 李惊雷,阮祥梅,刘静,等.头孢哌酮舒巴坦联合莫西沙星和阿米卡星对比联合替加环素治疗多重耐药鲍曼不动杆菌肺炎的药物经济学评价[J].中国药房,2019,30(23):3271-3275. DOI:10.6039/j.issn.1001-0408.2019.23.18.
[24] 王玉东,任松涛.序贯中药辅助治疗ICU多重耐药鲍曼不动杆菌肺炎的疗效评价[J].辽宁中医杂志,2020,47(7):87-90. DOI:10.13192/j.issn.1000-1719.2020.07.024.
[25] de Lima FCG, de Araújo AR, do Nascimento AV, et al. In vitro evaluation of human intravenous immunoglobulin in combination with antimicrobials and human serum against multidrug-resistant isolates of Acinetobacter baumannii[J]. Braz J Microbiol, 2023, 54(4):2845-2856. DOI: 10.1007/s42770-023-01153-5.
[26] 叶永强,何兰兰,刘桂玲,等.重症颅脑损伤患者合并多重耐药菌肺部感染病原菌分布、影像学特征以及风险预测模型的建立与验证[J].中国医学科学院学报,2022,44(4):636-642. DOI:10.3881/j.issn.1000-503X.14670.
[27] Mendes SG, Combo SI, Allain T, et al. Co-regulation of biofilm formation and antimicrobial resistance in Acinetobacter baumannii: from mechanisms to therapeutic strategies[J]. Eur J Clin Microbiol Infect Dis, 2023, 42(12):1405-1423. DOI: 10.1007/s10096-023- 04677-8.
[28] 唐梓宁,刘学武,兰前清,等.免疫抑制介导鲍曼不动杆菌耐药株感染性肺炎模型的建立[J].中华微生物学和免疫学杂志,2023,43(12):908-917. DOI:10.3760/cma.j.cn112309- 20230807-00031.
[29] İzci F, Ture Z, Dinc G, et al. The efficacy of mesenchymal stem cell treatment and colistin-fosfomycin combination on colistin-resistant Acinetobacter baumannii sepsis model[J]. Eur J Clin Microbiol Infect Dis, 2023, 42(11):1365-1372. DOI: 10.1007/s10096-023-04674-x.
|